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Abstract
Background:  Excitatory amino acid carrier 1 (EAAC1) is a glutamate transporter found in
neuronal tissues and is extensively expressed in the retina. EAAC1 plays a role in a variety of neural
functions, but its biological functions in the retina has not been fully determined. The purpose of
this study was to identify proteins regulated by EAAC1 in the retina of mice. To accomplish this,
we used a proteomics-based approach to identify proteins that are up- or down-regulated in
EAAC1-deficient (EAAC1-/-) mice.
Results: Proteomic analyses and two-dimensional gel electorphoresis were performed on the
retina of EAAC1-/- mice, and the results were compared to that of wild type mice. The protein spots
showing significant differences were selected for identification by mass spectrometric analyses.
Thirteen proteins were differentially expressed; nine proteins were up-regulated and five proteins
were down-regulated in EAAC1-/- retina. Functional clustering showed that identified proteins are
involved in various cellular process, e.g. cell cycle, cell death, transport and metabolism.
Conclusion:  We identified thirteen proteins whose expression is changed in EAAC-/- mice
retinas. These proteins are known to regulate cell proliferation, death, transport, metabolism, cell
organization and extracellular matrix.
Background
Glutamate is an excitatory neurotransmitter but high
extracellular concentrations of glutamate leads to neuro-
nal death by apoptosis [1]. Therefore, the glutamate con-
centration outside neuronal cells must be maintained at
low levels, and the concentration is controlled by excita-
tory amino acid transporters (EAATs). There are five types
of EAATs, EAAT1 through EAAT5 [2-5], and the sites of
expression of each is different in the central nervous sys-
tem. Glutamate-aspartate transporter (GLAST) or EAAT1
and glutamate transporter 1 (GLT-1) or EAAT2 are located
in glial cells, and GLT-1 is also found in presynaptic termi-
nals. Excitatory amino acid carrier 1 (EAAC1) or EAAT3
and EAAT4 are expressed in the postsynaptic terminals.
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In the cat retina, GLAST and EAAT4 are mainly expressed
in Mueller cells and astrocytes, and they play a significant
role in transporting glutamate [6]. GLT-1 is expressed in
bipolar cells, amacrine cells, and retinal ganglion cells
(RGCs). EAAT5 is expressed in the terminals of photore-
ceptor cells. EAAC1 is found in horizontal cells, amacrine
cells, and RGCs [6], and it is expressed in Mueller, ama-
crine, photoreceptor, and bipolar cells in humans and rats
[7]. Based on the wide range of expression sites, it is not
unreasonable to assume that EAAC1 has many functions
in the retina [7]. In addition, the expression of EAAC1 in
rat retinal cells in culture increases with high glutamate
loading and decreases with low oxygen loading. These
findings indicate that EAAC1 is involved in the glutamate
transport in the retina [8].
EAAC1 is involved in the neuronal uptake of cysteine
which is a substrate for the synthesis of gluthatione, a
major anti-oxidant [9]. The activity of EAAC1 is mediated
by Akt, a key survival signaling protein [10], and the activ-
ity of EAAC1 is regulated by protein kinase C and phos-
phatidylinositol-3-kinase (PI3K) [11]. Furthermore,
EAAC1 has anti-apoptotic activity by controlling XIAP and
inhibiting caspase-3 activation [12]. Thus, EAAC1 is not
only a glutamate transporter, but also cross-talks with
components of intracellular signaling pathways. So, com-
prehensive analyses are needed to clarify the multiple
functions of EAAC1. Here, we report description of thir-
teen proteins which changes their expression in retina of
EAAC1-/- mice.
Results
Two-dimensional proteomic maps of EAAC1-/- in mice 
retina
To identify the EAAC1-dependent proteins in the retina,
we compared the proteome of EAAC1-/- mice retinas with
that of wild type mice. Total lysates of each type of retina
were resolved by two-dimensional gel electrophoresis. We
detected an average of 300 protein spots on the two-
dimensional gels after silver staining (Figure 1). We ana-
lyzed five gels for each experimental condition to ensure
the reliability of the selection of spots with significant
changes.
A mother gel was constructed from five gels of EAAC1-/-
and ICR mice by PD-Quest software. The volume of all of
the protein spots was quantitatively analyzed, and the
maximum volume of one spot was 22,000. Weak spots,
whose volume in the matched pair spots was less than
2000, were deleted. Next, insignificant spots whose vol-
ume difference was less than seven times were also
deleted. Thirty-six spots remained, and the gels were
directly examined to check that the spots were present in
several of the original gels.
Finally, fourteen spots that had increased or decreased
volume in EAAC1-/- mice retinas were selected as signifi-
cant spots, and MALDI TOF mass spectrometry was per-
formed to identify the proteins. [see Additional file 1]
Clustering of identified proteins
We found that the expression of 9 of the 14 (64%) pro-
teins, P1 through P8 and P14 was increased in the EAAC1-
/- mice retina and five (36%) were decreased (Table 1). The
expressions of eight proteins, P1 through P8, were unde-
tectable in the ICR control mice and were defined as zero
in the PD-Quest-based analyses (+/- in Table 1). On the
other hand, three proteins, P9 through P11, were
expressed only in the ICR control mice (-/+ in Table 1).
Another three proteins, P12 through P14, were expressed
in both the EAAC1-/- and the ICR control mice retina. Two
spots, P12 and P13, were expressed predominantly in the
ICR mice retina, and P14 was expressed predominantly in
the EAAC1-/- mice retina.
Analyses of the identified proteins showed that the
absence of EAAC1 has the potential of altering different
cellular functions (Table 1). Clustering of identified pro-
teins using GoMiner indicated that ablation of EAAC1
may affect regulation of cell cycle, cell death, cellular
organization, metabolism, transport and extracellular
matrix (Figure 2). Thus, two cell membrane receptors, five
transcriptional factors, one regulator of cell signaling, and
one matrix protein were expressed in the EAAC1-/- but not
in the wild type mouse retina. PDGFR (P8) and GABAR
(P1) have already been identified as signaling proteins
and related to EAAC1 function. These findings demon-
strated that our approach not only detect previously sug-
gested functional links of EAAC1, but also confirmed the
validity of our technique. The identification of TPA, a reg-
ulator of sex-limitation 2 in two independent protein
spots, P10 and P14, suggests that these proteins are differ-
entially modified post-translationally. The identification
of novel proteins open for the possibility of novel mecha-
nism dependent on EAAC1 expression.
Discussion
The identification of proteins regulated by EAAC1 is
important for the understanding of the different functions
of EAAC1. We used the proteomic approach and detected
thirteen proteins that changed their expression in the
EAAC1-/- mouse retina and not in the wild type retina.
There have been reports of a correlation between the
PDGFR signaling system and EAAC1. PDGF-BB has been
reported to activate EAAC1 through PI3K in C6 gliomas
[13], but in EAAC1-/-  mice retina, the expression of
PDGFR-alpha was altered, which is not a receptor specific
to PDGF-BB. It has also been reported that PDGF-traffick-
ing is affected by the C-terminal of EAAC1 [14,15]. OurProteome Science 2007, 5:13 http://www.proteomesci.com/content/5/1/13
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results showed that the lack of EAAC1 led to an enhanced
expression of PDGFR-alpha (Table 1).
GABA is one of the metabolic substrates forming the met-
abolic cycle of glutamate that is taken in by cells [16].
Thus, the EAAC1-glutamate system is related to GABA,
which functions as another neurotransmitter [17]. How-
ever, there is a report that EAAC1 is not related to the syn-
thesis of GABA in rat retinas, so it was proposed that
EAAC1 and GABAR may form separate signaling
responses in the retina from that of the glutamate meta-
bolic system [18].
Proteins related to LEK1, p300-associated protein, pro-
teins related to Rho-GTPase, and Zinc finger protein 329,
have been identified as signaling factors (Table 1). LEK1 is
a SNAP-25 binding protein which is involved in vesicle-
recycling within the cells [19], and it also plays an impor-
tant role in cardiogenesis and development [20], but its
function in the nervous system is still undetermined.
p300 is an important transcription factor in several sign-
aling systems [21], and the expression of the co-activator
of p300 is increased in EAAC1-/- mouse retina.
Expression of the activator of Rho-dependent signaling,
which is a part of the Rho-GTPase family and controls the
cytoskeleton organization [22], was also increased in
EAAC1-/- mice retina. Zinc finger protein 329 has an effect
on neuronal differentiation [23] but its relationship to
EAAC1 is unknown.
Several proteins with not explored functions and no pre-
viously reported connections to EAAC1, e.g. Galnt7 [24],
microfibrillar associated protein 3, ANK repeat, and LEM
domain-containing protein.
Conclusion
Our proteomic study has identified thirteen proteins
which change their expression in EAAC1-/- mice retina, as
compared to normal retina. Functional clustering of these
proteins indicated that EAAC1 may affect various cellular
functions.
Methods
Animals
EAAC1-deficient (EAAC1-/-) mice (on ICR mice back-
ground) [25] were kindly provided by Dr. Kohichi Tanaka
Photographs of two-dimensional electrophoresis gels with annotation of the spots of identified proteins Figure 1
Photographs of two-dimensional electrophoresis gels with annotation of the spots of identified proteins. The left image shows 
a silver-stained gel of EAAC1-/- mouse retina and the right image is that of a wild-type mouse retina. The proteins spots that 
increased or decreased in response to the genomic EAAC1, and that were identified by PMF are shown. Spots P1 through P14 
represent the annotated spots. The pI gradient of the first dimension electrophoresis is shown on the top of the gels, and the 
migration of molecular mass markers for SDS-PAGE in the second dimension is shown on the side of the gel. Representative 
gel images are shown.Proteome Science 2007, 5:13 http://www.proteomesci.com/content/5/1/13
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(Tokyo Medical and Dental University). For controls, wild
type ICR mice were purchased from CLEA Japan, Inc
(Tokyo, Japan). All animals were maintained in clear plas-
tic cages with standard 12:12 light:dark cycle and handled
in accordance with the Guide for the Care and Use of Lab-
oratory Animals by the USA National Institutes of Health.
Sample preparation
Mice were anesthetized with diethylether, and the eyes
were enucleated. The retinas were carefully isolated from
the choroid in phosphate-buffered saline (PBS). The iso-
lated retinas were solubilized in sample buffer [8 M urea,
4% CHAPS, 0.5% dithiothreitol (DTT), IPG buffer, pH 3–
10], and aliquots of the lysates were stored at -70 degrees.
The protein concentration was measured by the Bradford
assay.
Two-dimensional electrophoresis
Two-dimensional electrophoresis and protein identifica-
tion were performed as described in detail [26]. Isoelec-
trofocusing was performed on the strips with an
immobilized pH gradient (pH 3–10 non-linear gradient,
18 cm: GE Healthcare). First-dimension isoelectrophore-
sis was performed in IPGphor (GE Healthcare) according
to manufacturer's instructions. After the isoelctrofocusing,
the strips were placed in equilibration buffer-1 (50 mM
Tris-HCl, pH 8.8, 6.0 M urea, 2.0% SDS, 30% glycerol, 1%
DTT) and then in equilibration buffer-2 (50 mM Tris-HCl,
pH 8.8, 6.0 M urea, 2.0% SDS, 30% glycerol, 4% iodoa-
cetamide). The equilibrated strips were loaded onto SDS-
containing 12% polyacrylamide, and SDS-polyacryla-
mide gel electrophoresis (PAGE) was performed.
After the electrophoresis, the gels were fixed in 7.5% acetic
acid and 20% methanol, and sensitized in 25% ethanol,
Table 1: Differentially expressed proteins identified by proteomics from retinas of EAAC1-/- (EAAC1KO) and wild type ICR mice 
retina. a) P1–P14, ID number of spots. b) Probability, sequence coverage, and theoretical value of pI and Mr were obtained from the 
Pro Found search. The calculation of experimental pI and Mr was based on the migration of the protein on a 2D gel. c) Changes 
present the EAAC1-/- mice retinal protein volume ratio compared with that of ICR mice. (+/-; EAAC1-/- mice only, -/+; wild type ICR 
mice only)
a) b) c)
Theoretical 
value
Experimenta
l value
Changes
Spot Protein Probability Sequence 
coverage(%)
ncbi ID pI Mr 
(kDa)
pI Mr 
(kDa)
EAAC1K
O/ICR
Spots identified only in the EAAC1 KO mice retina
P1 gamma-aminobutyric acid (GABA-A) 
receptor, subunit beta1
1.0e + 000 17 NP_032095 9.1 54.37 8.9 56 +/-
P2 p300 transcriptional cofactor JMY 1.0e + 000 12 NP_001004185 6.5 82.04 9.2 72 +/-
P3 LEK1 1.0e + 000 6 AAF07196 4.9 284.46 5.9 210 +/-
P4 unnamed protein product 9.9e - 001 16 BAB22659 6.0 71.53 7.9 78 +/-
ANK repeat and LEM domain 
containing
Q6P1H6
P5 unnamed protein product 1.0e + 000 12 BAB30425 10.1 57.84 8.8 66 +/-
Zin finger 329 NP_080322
P6 RIKEN cDNA 2600017A12 1.0e + 000 19 AAH37711 4.3 86.68 8.8 74 +/-
HIV TAT Spec factor 1 NP_082518
P7 striated muscle activator of Rho-
dependent signaling
1.0e + 000 34 AAM28877 6.8 42.98 5.9 44 +/-
P8 Alpha platelet-derived growth factor 
receptor precursor
1.0e + 000 13 P26618 5.0 123.68 6.0 112 +/-
Spots identified only in the ICR mice retina
P9 Galnt7 protein 1.0e + 000 24 AAH49907 6.4 42.70 4.9 34 -/+
P10 TPA : regulator of sex-limitation 2 1.0e + 000 29 DAA01848 9.8 59.05 9.6 56 -/+
P11 mKIAA0626 protein 1.0e + 000 21 BAC65614 4.8 39.57 7.1 38 -/+
microfibrillar associated protein 3 like NP_082032
Spots identified in both EAAC1 KO and ICR mice retina
Spots with high expression in ICR mice retina
P12 hypothetical protein 9.9e - 001 23 XP_357614 8.6 27.86 4.0 26 0.11
P13 unnamed protein product 1.0e + 000 40 BAC26443 12.2 29.52 7.4 29 0.14
Spots with high expression in EAAC1 KO mice retina
P14 TPA : regulator of sex-limitation 2 8.8e - 001 23 DAA01848 9.8 59.05 8.3 56 7.06Proteome Science 2007, 5:13 http://www.proteomesci.com/content/5/1/13
Page 5 of 6
(page number not for citation purposes)
0.2% sodium thiosulfate, and 3.4% sosium acetate. The
gels were then stained with 0.25% silver nitrate and devel-
oped with 2.5% sodium carbonate and 0.04% formalde-
hyde.
Gel analyses
Silver-stained gels were scanned by an image scanner
(EPSON) and analyzed with calculation of the volumes of
the spots with the PD-Quest software (BioRad) following
the manufacturer's instructions. Five gels from each type
of mouse were prepared and a master gel was generated
for each type of mouse. The values of the volume of each
matched spot on the master gels were compared. Spots
with differences in expression were then identified by
mass spectrometry.
Protein identification
The excited protein-containing spots were destained with
30 mM potassium ferricyanide and 100 mM sodium thio-
sulfate. Then, the gel pieces were dipped in 0.1 M sodium
hydrocarbonate and washed with acetnitril. After the gel
pieces were dryed, in-gel digestion was performed with
trypsin. Then, 10% trifluoroacetic acid (TFA) and ace-
tonitrile were used to extract the peptides, and the extract
was desalted on a nano-column. After washing the col-
umn with 0.1% TFA, the matrix was eluted with acetnitril
Involvement of the EAAC1-affected proteins in various cellular physiological processes is shown by direct acyclic graph (DAG) Figure 2
Involvement of the EAAC1-affected proteins in various cellular physiological processes is shown by direct acyclic graph (DAG). 
Proteins in various nodes are annotated and arrows show corresponding nodes. The first level of affected process is anno-
tated.
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containing alpha-cyano-4-hydroxycinnamic acid directly
onto the MALDI target. Spectra were generated on a
MALDI-TOF-MS (Bruker Daltonics). The spectra were
internally calibrated using known internal tryptic peptides
from trypsin and searches were made in the NCBI
sequences using ProFound. The search results were evalu-
ated by considering the probability, the Z-value, peptide
coverage, and correspondence to experimental pI and
molecular mass.
Functional clustering
For functional clustering, proteins were annotated in
Gene Ontology [27] and subjected to a search using GoM-
iner tool [28].
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